AzTrials
AzTrials

Alveolar Ridge PreservationNCT07571863

Radiographic And Histomorphometric Assessment Following Alveolar Ridge Preservation Using Chitosan Gel Versus Normal Socket Healing In Posterior Maxillary and Mandibular Region

A study testing Chitosan gel Sigma-Aldrich® in socket preservation and Gelfoam® absorbable gelatin sponge in socket preservation post extraction in people with Alveolar Ridge Preservation and Socket Preservation, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

After tooth extraction, the alveolar bone, which supports the teeth, undergoes a natural resorption process. This bone loss can be significant, especially in the first few months post-extraction, leading to a reduction in both bone height and width. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Chitosan gel Sigma-Aldrich® in socket preservation and Gelfoam® absorbable gelatin sponge in socket preservation post extraction
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteEgypt
Study dates
4 Dec 2024to 1 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient having at least one hopeless tooth in posterior maxillary and mandibular area
  • 18 years old or older.
  • Motivated patients agree to sign the written informed consent and complete the follow up period
  • Medically fit patients.
  • No acute infections, pus formation, socket and bony discharges.
  • Compliant the patient to ensure the follow up

Who cannot join

  • Heavy smokers (more than 10 cigarettes per day or an electronic cigarette dose of >6 mg/ml of nicotine).
  • Pregnant females.
  • Presence of active infection or severe inflammation in the intervention zone.
  • Relevant medical history that contraindicates implant surgery.
  • Immunosuppression (eg. Hiv, solid-organ transplants).
  • Head and neck-irradiated patients in the past 5 years.
Show all 14Show fewer
  • Regular intake of bisphosphonates, anticoagulants, or anti-inflammatories.
  • Chronic drug abuse or alcoholic habits.
  • Patients with poor oral hygiene (full-mouth plaque score and full-mouth bleeding score >15%) and lack of motivation.
  • Uncontrolled diabetes (reported levels of glycated haemoglobin exceeding 7%).
  • Active periodontal disease.
  • Patients with significant comorbidity such as recent heart attack or coagulation disorder.
  • Patients with a history of allergies.
  • Mentally and physically handicapped patients.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculaty of Dentistry Cairo University, Cairo, Cairo 35855

    Cairo

Other trials in Egypt

About this study

Official title: Radiographic And Histomorphometric Assessment Following Alveolar Ridge Preservation Using Chitosan Gel Versus Normal Socket Healing In Posterior Maxillary and Mandibular Region A Randomized Controlled Clinical Trial

After tooth extraction, the alveolar bone, which supports the teeth, undergoes a natural resorption process. This bone loss can be significant, especially in the first few months post-extraction, leading to a reduction in both bone height and width. This resorption can compromise the structural foundation required for future dental restorations, such as implants, bridges, or dentures.

Socket preservation technique has been proposed since years as a technique to preserve alveolar bone following extraction and has proved excellent clinical efficacy over years.

Read more

Several materials have been proposed for alveolar ridge preservation, such as autografts, allografts, xenografts, and alloplasts, each with its own set of advantages and limitations. However, these materials may have limitations, including potential immunogenic responses and variable integration.

Thus, there is always a need to explore and validate new materials to mitigate these issues. This study aims to tests one of these new materials named chitosan gel to investigate whether the application of this chitosan gel following posterior mandibular tooth extraction would better preserve alveolar ridge dimensions and improve bone quality compared to normal socket healing or not ?.

Read the detailed description

Tooth extraction often leads to significant alveolar ridge resorption, which can complicate future dental implant placement and prosthetic rehabilitation . Socket preservation techniques aim to mitigate these dimensional changes, and various materials have been investigated for this purpose .

Chitosan, a natural biopolymer derived from chitin, has shown promising results in tissue engineering and regenerative medicine due to its biocompatibility, biodegradability, and antimicrobial properties.

Previous studies have demonstrated that chitosan can enhance bone regeneration and wound healing, making it a potential candidate for socket preservation. However, there is limited clinical evidence comparing chitosan to natural socket healing in the context of alveolar ridge preservation.

This trial aims to fill this gap by conducting a detailed histomorphometric analysis and assessing alveolar ridge dimensional changes post-extraction. Histomorphometric analysis will provide insights into the quality and quantity of new bone and soft tissue formation, offering a microscopic evaluation of the regenerative process. By comparing these parameters between chitosan-treated sockets and those that heal naturally, the study seeks to determine if chitosan can better preserve ridge dimensions and improve tissue regeneration quality.

The findings from this trial could have significant clinical implications, potentially leading to improved socket preservation techniques and materials. Enhanced preservation of the alveolar ridge could reduce the need for additional grafting procedures, facilitate easier and more predictable implant placement, and ultimately improve patient outcomes.

Therefore, this study aims to provide high-quality scientific evidence on the efficacy of chitosan gel in socket preservation, contributing to the existing body of knowledge and guiding future clinical practices.

Review of literature:

Tooth extraction is a common dental procedure that often leads to significant changes in the alveolar ridge, the bony structure that supports the teeth. Understanding the extent and nature of these changes is crucial for planning subsequent dental treatments, such as implant placement and prosthetic rehabilitation.

The alveolar ridge undergoes both horizontal and vertical resorption following tooth extraction. This resorption is a natural physiological response to the loss of the tooth and its associated periodontal ligament, which plays a crucial role in maintaining alveolar bone integrity. The absence of mechanical stimulation from the tooth leads to bone remodeling and resorption.

Several studies have quantified the dimensional changes in the alveolar ridge post-extraction. Araújo and Lindhe conducted an experimental study in dogs and found that the majority of bone loss occurs within the first three months following extraction. They reported an average horizontal bone loss of 3.8 mm and vertical bone loss of 1.24 mm within six months. These findings were corroborated by Tan et al, who conducted a systematic review and reported similar magnitudes of bone loss in humans.

Several factors can influence the extent of alveolar ridge resorption, including the patient's age, systemic health, smoking status, and the presence of periodontal disease. For instance, patients with uncontrolled diabetes or those who smoke are at a higher risk of accelerated bone loss. Additionally, the surgical technique used during extraction, such as flapless versus flap procedures, can also impact the degree of resorption.

To mitigate alveolar ridge resorption, various socket preservation techniques have been developed. These techniques involve the use of grafting materials and barriers to maintain the ridge dimensions post-extraction. Darby et al. reviewed different ridge preservation techniques and concluded that they can significantly reduce the amount of bone loss compared to natural healing. Common materials used for socket preservation include autografts, allografts, xenografts, and alloplasts, each with its own set of advantages and limitations.

Socket preservation techniques are employed to mitigate the alveolar ridge resorption that typically follows tooth extraction. These techniques aim to maintain the ridge dimensions, thereby facilitating future dental implant placement and improving prosthetic outcomes.

Autografts, which are taken from the patient's own body, typically from intraoral sites like the mandibular ramus or chin, and are considered the gold standard due to their osteogenic potential, though their use is limited by donor site morbidity and availability. Allografts, sourced from human donors and processed for sterilization, such as freeze-dried bone allograft (FDBA), are widely used for their osteoconductive properties and availability, significantly reducing ridge resorption compared to extraction alone.

Xenografts, derived from other species like bovine bone, such as deproteinized bovine bone mineral (DBBM), offer osteoconductive properties and slow resorption rates, providing long-term volume stability.

Alloplasts, synthetic graft materials including hydroxyapatite, beta-tricalcium phosphate (β-TCP), and bioactive glass, are biocompatible and osteoconductive, offering an alternative to biological grafts without the risk of disease transmission

Barrier membranes are often used in conjunction with grafting materials to prevent the ingrowth of soft tissue into the socket and to maintain space for bone regeneration. These membranes can be classified into two main types: resorbable membranes, made from materials such as collagen or polylactic acid, which gradually degrade and are absorbed by the body, eliminating the need for a second surgery but potentially offering limited mechanical stability and non-resorbable membranes, made from materials like expanded polytetrafluoroethylene (ePTFE), which provide excellent mechanical stability and space maintenance but require a second surgical procedure for removal, potentially increasing patient morbidity

Techniques and protocols for socket preservation include flapless extraction, which involves minimal soft tissue manipulation to preserve blood supply and reduce postoperative complications, often combined with immediate grafting to optimize outcomes.

The use of growth factors and biologics, such as platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), has been explored to enhance the regenerative potential of grafting materials, accelerating healing and improving the quality of regenerated bone . Additionally, emerging research on stem cell therapy, particularly with mesenchymal stem cells (MSCs), shows promising results in socket preservation as these cells can differentiate into osteoblasts and contribute to bone regeneration .

The cost-effectiveness and accessibility of socket preservation techniques are important considerations for clinical practice. While autografts and allografts are effective, they can be expensive and may not be readily available in all settings. Alloplasts and xenografts offer more cost-effective alternatives, and ongoing research aims to optimize their performance and reduce costs .

Chitosan gel, a natural biopolymer derived from chitin, has gained attention in tissue engineering and regenerative medicine due to its biocompatibility, biodegradability, and antimicrobial properties. Muzzarelli et al demonstrated that Chitosan gel-based scaffolds could support the regeneration of cartilage and bone, highlighting its potential in regenerative applications. Additionally, Chitosan gel's ability to form hydrogels and its hemostatic properties make it particularly suitable for dental applications.

Despite the promising properties of Chitosan gel, there is limited clinical evidence comparing its effectiveness to natural socket healing in the context of alveolar ridge preservation. A few studies have explored the use of Chitosan gel in dental applications, but comprehensive clinical trials are lacking. For instance, Park investigated the use of Chitosan gel membranes for guided bone regeneration and found favorable outcomes in terms of bone formation and biocompatibility.

Another study by Kim et al evaluated the use of Chitosan gel-collagen membranes in periodontal regeneration and reported enhanced bone and soft tissue healing.

Histomorphometric analysis is a critical tool for evaluating the quality and quantity of new bone and soft tissue formation at a microscopic level. This method provides detailed insights into the regenerative process, allowing for a comprehensive assessment of different socket preservation materials .

The findings from this trial could have significant clinical implications. Enhanced preservation of the alveolar ridge could reduce the need for additional grafting procedures, facilitate easier and more predictable implant placement, and ultimately improve patient outcomes Therefore, this study aims to provide high-quality scientific evidence on the efficacy of Chitosan gel in socket preservation, contributing to the existing body of knowledge and guiding future clinical practices. Moreover, the use of Chitosan gel could offer a cost-effective and readily available alternative to other grafting materials, potentially broadening the scope of socket preservation techniques

Being tested
Chitosan gel Sigma-Aldrich® in socket preservation, Gelfoam® absorbable gelatin sponge in socket preservation post extraction
Keywords
chitosan gel

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Chitosan gel Sigma-Aldrich® in socket preservationProcedure or surgery

    The interventional group, involves the application of Chitosan gel extract to the extraction socket immediately after tooth extraction. The procedure includes performing the tooth extraction using standard techniques, applying Chitosan gel extract directly into the extraction socket, covering the socket with gelfoam in place, suturing the site stabilized in situ with a Vicryl Plus external criss-cross inverting horizontal mattress suture to ensure stability and containment of the Chitosan gel extract, and following standard postoperative care instructions. Specimen preparation and histomorphometric analysis.

  • Gelfoam® absorbable gelatin sponge in socket preservation post extractionProcedure or surgery

    The control group, involves allowing the extraction socket to heal naturally without any additional intervention. The procedure includes performing the tooth extraction using standard techniques, allowing the socket to heal without the application of any grafting materials or membranes, and following standard postoperative care instructions to maintain oral hygiene and manage pain. Postoperative Care and follow up: (Elfana et al., 2021)

Study groups in NCT07571863
Study groupRoleWhat they receive
ChitogelExperimentalChitogel (chitosan gel) for socket preservation
Receives: Procedure: Chitosan gel Sigma-Aldrich® in socket preservation
GelfoamActive comparatorAbsorbable gelatin sponge (gelfoam) for socket preservation
Receives: Procedure: Gelfoam® absorbable gelatin sponge in socket preservation post extraction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in radiographic horizontal ridge width at 3 mm below the most coronal aspect of the crest

    CBCT scans will be performed at baseline and 6 months postoperatively. Measurements will be taken at both time points using identical reference points and lines. To establish a reference, the most apical point of the extraction socket will be identified on the baseline image, and two reference lines will be drawn. The vertical reference line will be placed at the midpoint of the extraction socket, intersecting the apical reference point. Additionally, a horizontal reference line will be drawn perpendicular to the vertical line, passing through the apical reference point.

    The horizontal ridge width will be measured at three specific levels: 1 mm, 3 mm, and 5 mm below the most coronal aspect of the crest. These measurements will be denoted as HW-1, HW-3, and HW-5, respectively.

    Measured: 6 months postoperatively

Secondary outcomes (4)
  1. Change in radiographic horizontal ridge width at 1mm and 5mm below the most coronal aspect of the crest.

    The horizontal ridge width will be measured at three specific levels: 1 mm, 3 mm, and 5 mm below the most coronal aspect of the crest. These measurements will be denoted as HW-1, HW-3, and HW-5, respectively.

    Measured: 6 months postoperatively

  2. Change in radiographic buccal and palatal ridge height

    The height of the alveolus will be measured at the midbuccal aspect (BH) and midlingual aspect (LH).

    Measured: at baseline, at 6 months post operatively

  3. Percentage of new vital bone formation

    The biopsies will be stored in a 10% formalin solution for preservation. Afterward, they will undergo decalcification in EDTA for a duration of four weeks. Following decalcification, the specimens will be processed and embedded in paraffin to create tissue blocks. Longitudinal sections of 5μm thickness will be cut from the paraffin blocks. These sections will be stained using hematoxylin and eosin (H\&E) or Masson's trichromatic (MT) stains for histological evaluation and histomorphometric analysis. Photomicrographs of the stained sections will be captured using a digital light microscope (Leica Digital Microscope, Leica Microsystems, Germany).

    Histomorphometric analysis will be performed to quantify the area percentage occupied by bone, graft particles, and soft tissue stroma relative to the total examined histological area.The software will automatically convert the measurement units (pixels) produced by the program into actual micrometer units for accurate quantification.

    Measured: 6 months postoperatively

  4. Wound healing and pain

    assessed using the Modified Healing Index (MHI). The MHI is a scale out of 7 points that evaluates various aspects of wound healing, including tissue color, presence of granulation tissue, and epithelialization. Higher scores on the MHI indicate better healing outcomes.

    Measured: at baseline,1 day, 5 days, 10 days, 6 months postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2026
  2. Study start4 Dec 2024
  3. Primary completion1 Oct 2025
  4. Study completion1 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07571863
Sponsor's protocol ID
PER 6-3-1 october-2024
Status last verified
Apr 2026
First submitted
15 Apr 2026
Last updated
6 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Chitosan gel Sigma-Aldrich® in socket preservation and Gelfoam® absorbable gelatin sponge in socket preservation post extraction in people with Alveolar Ridge Preservation and Socket Preservation, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in radiographic horizontal ridge width at 3 mm below the most coronal aspect of the crest (time frame: 6 months postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in